O-1103 |
H-γ-Glu-Gly-Gly-OH |
C9H15N3O6 |
261.24 |
13640-39-6 |
H-Glu(Gly-Gly-OH)-OH |
O-1104 |
Ophthalmic Acid |
C11H19N3O6 |
289.29 |
495-27-2 |
H-Glu(Abu-Gly-OH)-OH |
O-1201 |
Gliadorphin-7, α/β-Gliadin (43-49), GD-7, Prolamin (43-49), Gluteomorphin |
C43H57N9O11 |
875.98 |
107936-65-2 |
H-Tyr-Pro-Gln-Pro-Gln-Pro-Phe-OH |
O-1202 |
? |
C13H15N3O3 |
261.28 |
7360-09-0 |
H-Trp-Gly-OH |
O-1301 |
Opiorphin |
C29H48N12O8 |
692.78 |
864084-88-8 |
H-Gln-Arg-Phe-Ser-Arg-OH |
O-1302 |
(Pyr1)-Opiorphin |
C29H45N11O8 |
675.75 |
1189350-60-4 |
Pyr-Arg-Phe-Ser-Arg-OH |
O-1401 |
Osteoblast Activating Peptide (human), OBAP (human) |
C120H196N38O37S |
2795.18 |
? |
H-Leu-Asp-Leu-Asn-Leu-Glu-Leu-Ser-Lys-Phe-Arg-Met-Pro-Gln-Pro-Ser-Ser-Gly-Arg-Glu-Ser-Pro-Arg-His-OH |
O-1402 |
Osteoblast Activating Peptide (mouse, rat), OBAP (mouse, rat) |
C120H196N38O37 |
2763.11 |
1222950-80-2 |
H-Leu-Asp-Leu-Asn-Leu-Asp-Leu-Ser-Lys-Phe-Arg-Leu-Pro-Gln-Pro-Ser-Ser-Gly-Arg-Glu-Ser-Pro-Arg-His-OH |
P-0101 |
Mitogenic Pentapeptide
Pam3Cys-Ser-Ser-Asn-Ala-OH, Pam3CSSNA |
C67H124N6O14S |
1269.82 |
87173-03-3 |
Palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-Ser-Ser-Asn-Ala-OH |
P-0102 |
Pam3Cys-Ala-Gly-OH, Pam3CAG |
C59H111N3O9S |
1038.61 |
117858-54-5 |
Palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-Ala-Gly-OH |